Masato Ishida1, Yuki Kuroiwa1, Emiko Yoshida1, Masayo Sato1, Dominika Krupa2, Nathaniel Henry2, Kei Ikeda3, Yuko Kaneko4. 1. a Medical Development Unit Japan , Eli Lilly Japan K.K. , Kobe , Japan. 2. b QuintilesIMS , London , UK. 3. c Department of Allergy and Clinical Immunology , Chiba University Hospital , Chiba , Japan. 4. d Division of Rheumatology, Department of Internal Medicine , Keio University School of Medicine , Tokyo , Japan.
Abstract
OBJECTIVES: To identify, describe and summarize evidence on residual symptoms and disease burdens in rheumatoid arthritis (RA) patients qualified as being in remission or low disease activity (LDA). METHODS: A systematic literature review (SLR) was conducted according to Cochrane collaboration guidelines. The population of interest was adult patients with RA in remission or LDA. The reported outcomes of interest were any symptoms or burdens. RESULTS: Fifty-one publications were identified through an eDatabase search. Together with 17 articles found through other sources, 68 were included for full text review. The most commonly reported residual symptoms were pain (number of studies = 25), fatigue (n = 21) and morning stiffness (n = 5). Reported disease burdens included mental health (n = 15), sleep disturbances (n = 7) and work productivity (n = 5), impairment in quality of life (n = 21), and functional disability (n = 34). Substantial residual symptoms and disease burdens were found to be present in patients in remission or LDA. CONCLUSION: This is the first SLR to investigate residual symptoms and disease burdens in RA patients in remission or LDA. The results indicate that despite achieving conventional clinical targets, the disease continues to affect patients, suggesting the existence of unmet need under the current treatment paradigm.
OBJECTIVES: To identify, describe and summarize evidence on residual symptoms and disease burdens in rheumatoid arthritis (RA) patients qualified as being in remission or low disease activity (LDA). METHODS: A systematic literature review (SLR) was conducted according to Cochrane collaboration guidelines. The population of interest was adult patients with RA in remission or LDA. The reported outcomes of interest were any symptoms or burdens. RESULTS: Fifty-one publications were identified through an eDatabase search. Together with 17 articles found through other sources, 68 were included for full text review. The most commonly reported residual symptoms were pain (number of studies = 25), fatigue (n = 21) and morning stiffness (n = 5). Reported disease burdens included mental health (n = 15), sleep disturbances (n = 7) and work productivity (n = 5), impairment in quality of life (n = 21), and functional disability (n = 34). Substantial residual symptoms and disease burdens were found to be present in patients in remission or LDA. CONCLUSION: This is the first SLR to investigate residual symptoms and disease burdens in RApatients in remission or LDA. The results indicate that despite achieving conventional clinical targets, the disease continues to affect patients, suggesting the existence of unmet need under the current treatment paradigm.
Authors: Andrew C Heisler; Jing Song; Dorothy D Dunlop; Alyssa Wohlfahrt; Clifton O Bingham; Marcy B Bolster; Daniel J Clauw; Wendy Marder; Kristine Phillips; Tuhina Neogi; Yvonne C Lee Journal: Arthritis Care Res (Hoboken) Date: 2020-07-21 Impact factor: 4.794
Authors: Déborah Puyraimond-Zemmour; Benjamin Granger; Anna Molto; Cécile Gaujoux-Viala; Francis Guillemin; Adeline Ruyssen-Witrand; Maxime Dougados; Bruno Fautrel; Laure Gossec Journal: Arthritis Res Ther Date: 2019-02-19 Impact factor: 5.156
Authors: Yomei Shaw; Delphine S Courvoisier; Almut Scherer; Adrian Ciurea; Thomas Lehmann; Veronika K Jaeger; Ulrich A Walker; Axel Finckh Journal: RMD Open Date: 2021-04
Authors: Peter C Taylor; Rieke Alten; Jose María Álvaro Gracia; Yuko Kaneko; Chad Walls; Amanda Quebe; Bochao Jia; Natalia Bello; Jorge Ross Terres; Roy Fleischmann Journal: RMD Open Date: 2022-03
Authors: Bruno Fautrel; Bruce Kirkham; Janet E Pope; Tsutomu Takeuchi; Carol Gaich; Amanda Quebe; Baojin Zhu; Inmaculada de la Torre; Francesco De Leonardis; Peter C Taylor Journal: J Clin Med Date: 2019-09-05 Impact factor: 4.241